The addition of the DOASENSE product suite complements the recent European IVDR approval of the Coag-Sense ® PT/INR Monitoring System for patient self-testing, positioning CoaguSense as a versatile ...

Clinic-free approach tests the waters in the U.S.

November 22, 2011 — Patients receiving long-term, steady-dose warfarin therapy who have had stable international normalized ratios (INRs) for at least 6 months can safely go 12 weeks between dose ...

For patients on long-term oral anticoagulation therapy, use of point-of-care devices is associated with lower rates of death and major thromboembolic events compared with laboratory determinations of ...

(HealthDay News) — For hospitalized patients, international normalized ratio (INR) monitoring less frequently than daily is associated with increased odds of warfarin-associated adverse events, ...